$PDEX
PRO DEX INC Stock $pdex

$pdex Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000107997323001429 Filed on October 13, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023 Q1
Revenue	$11.94M	$10.64M	$13.08M
YoY Change	7.68%	-15.66%	41.17%
Cost Of Revenue	$8.280M	$7.280M	$9.268M
YoY Change	1.83%	-20.64%	44.65%
Gross Profit	$3.658M	$3.360M	$3.811M
YoY Change	23.75%	-2.38%	33.34%
Gross Profit Margin	30.64%	31.58%	29.14%
Selling, General & Admin	$1.020M	$1.050M	$1.033M
YoY Change	-5.29%	-30.6%	-11.33%
% of Gross Profit	27.88%	31.25%	27.11%
Research & Development	$805.0K	$700.0K	$713.0K
YoY Change	-13.35%	-3.58%	8.36%
% of Gross Profit	22.01%	20.83%	18.71%
Depreciation & Amortization	$282.0K	$270.0K	$210.0K
YoY Change	46.11%	50.0%	16.67%
% of Gross Profit	7.71%	8.04%	5.51%
Operating Expenses	$1.825M	$1.750M	$1.746M
YoY Change	-9.02%	-21.84%	-4.95%
Operating Profit	$1.833M	$1.610M	$2.065M
YoY Change	92.95%	33.83%	102.25%
Interest Expense	$133.0K	$3.580M	$131.0K
YoY Change	2.31%	1058.58%	-133.85%
% of Operating Profit	7.26%	222.36%	6.34%
Other Income/Expense, Net	-$2.662M		$122.0K
YoY Change	-873.84%		-152.59%
Pretax Income	-$829.0K	$5.190M	$1.768M
YoY Change	-164.06%	248.09%	178.86%
Income Tax	-$214.0K	$1.390M	$455.0K
% Of Pretax Income		26.78%	25.74%
Net Earnings	-$615.0K	$3.810M	$1.313M
YoY Change	-157.16%	171.17%	184.2%
Net Earnings / Revenue	-5.15%	35.81%	10.04%
Basic Earnings Per Share	-$0.17		$0.37
Diluted Earnings Per Share	-$0.17	$1.06	$0.36
COMMON SHARES
Basic Shares Outstanding	3.547M shares	3.545M shares	3.544M shares
Diluted Shares Outstanding	3.547M shares		3.623M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.006M	$11.59M	$4.771M
YoY Change	45.56%	622.63%	-19.0%
Cash & Equivalents	$1.904M	$2.936M	$2.088M
Short-Term Investments	$6.102M	$8.655M	$2.683M
Other Short-Term Assets	$790.0K	$790.0K	$1.919M
YoY Change	-47.85%	-47.33%	15.39%
Inventory	$16.26M	$16.17M	$15.15M
Prepaid Expenses		$296.0K
Receivables	$11.03M	$9.952M	$10.57M
Other Receivables	$420.0K	$0.00	$0.00
Total Short-Term Assets	$31.42M	$30.98M	$31.15M
YoY Change	-1.29%	-0.6%	10.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.952M	$5.079M	$5.162M
YoY Change	2.06%	-62.16%	-61.3%
Goodwill
YoY Change
Intangibles	$75.00K	$81.00K	$87.00K
YoY Change	-30.56%	-31.36%
Long-Term Investments	$5.090M	$7.520M	$1.534M
YoY Change	169.45%	322.71%	-13.72%
Other Assets	$42.00K	$42.00K	$42.00K
YoY Change	0.0%	-94.99%	-91.68%
Total Long-Term Assets	$18.16M	$20.84M	$15.83M
YoY Change	12.59%	28.99%	0.29%
TOTAL ASSETS
Total Short-Term Assets	$31.42M	$30.98M	$31.15M
Total Long-Term Assets	$18.16M	$20.84M	$15.83M
Total Assets	$49.59M	$51.82M	$46.98M
YoY Change	3.38%	9.5%	7.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.740M	$2.261M	$3.068M
YoY Change	-22.8%	-39.88%	-13.16%
Accrued Expenses	$2.701M	$3.135M	$2.425M
YoY Change	-16.76%	13.96%	46.79%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.840M	$3.830M	$3.114M
YoY Change	-13.86%	16.59%	89.65%
Total Short-Term Liabilities	$8.281M	$9.676M	$10.14M
YoY Change	-29.06%	-10.49%	31.35%
LONG-TERM LIABILITIES
Long-Term Debt	$8.570M	$8.910M	$9.247M
YoY Change	-13.63%	-13.07%	-12.56%
Other Long-Term Liabilities	$1.530M	$1.640M	$1.745M
YoY Change	-21.7%	-36.87%	-47.36%
Total Long-Term Liabilities	$10.11M	$10.56M	$10.99M
YoY Change	-14.88%	-17.83%	-20.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.281M	$9.676M	$10.14M
Total Long-Term Liabilities	$10.11M	$10.56M	$10.99M
Total Liabilities	$18.39M	$20.23M	$21.14M
YoY Change	-21.91%	-14.48%	-2.21%
SHAREHOLDERS EQUITY
Retained Earnings	$24.21M	$24.82M	$19.25M
YoY Change	41.88%	55.28%	21.0%
Common Stock	$6.987M	$6.767M	$6.585M
YoY Change	-4.99%	-11.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.20M	$31.59M	$25.84M
YoY Change
Total Liabilities & Shareholders Equity	$49.59M	$51.82M	$46.98M
YoY Change	3.38%	9.5%	7.04%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$615.0K	$3.810M	$1.313M
YoY Change	-157.16%	171.17%	184.2%
Depreciation, Depletion And Amortization	$282.0K	$270.0K	$210.0K
YoY Change	46.11%	50.0%	16.67%
Cash From Operating Activities	$392.0K	$620.0K	$2.338M
YoY Change	-86.45%	-111.74%	997.65%
INVESTING ACTIVITIES
Capital Expenditures	$126.0K	$150.0K	$135.0K
YoY Change	-29.21%	-140.76%	-168.18%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Cash From Investing Activities	-$126.0K	-$160.0K	-$135.0K
YoY Change	40.0%	-139.9%	-34.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.298M	370.0K	-497.0K
YoY Change	52.17%	-61.7%	-0.2%
NET CHANGE
Cash From Operating Activities	$392.0K	620.0K	2.338M
Cash From Investing Activities	-$126.0K	-160.0K	-135.0K
Cash From Financing Activities	-$1.298M	370.0K	-497.0K
Net Change In Cash	-$1.032M	830.0K	1.706M
YoY Change	-152.95%	-121.22%	-447.45%
FREE CASH FLOW
Cash From Operating Activities	$392.0K	$620.0K	$2.338M
Capital Expenditures	$126.0K	$150.0K	$135.0K
Free Cash Flow	$266.0K	$470.0K	$2.203M
YoY Change	-90.2%	-109.57%	436.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000788920
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021	pdex	Stock Issued During Period Value With Performance Award Vesting StockIssuedDuringPeriodValueWithPerformanceAwardVesting		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023	pdex	Stock Issued During Period Value With Performance Award Vesting StockIssuedDuringPeriodValueWithPerformanceAwardVesting		usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023	pdex	Bad Debt Expense Recovery BadDebtExpenseRecovery		usd
CY2023	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment		usd
CY2022	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022	pdex	Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock		usd
CY2023	pdex	Cashless Stock Option Exercise CashlessStockOptionExercise		usd
CY2022Q4	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet		usd
CY2023Q1	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet		usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2022	pdex	Income Tax Reconciliation Share Based Compensation IncomeTaxReconciliationShareBasedCompensation		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent		pure
CY2023Q2	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross		usd
CY2022Q2	pdex	Section174 Capitalization Section174Capitalization		usd
CY2022Q2	pdex	Deferred Tax Assets Deferred State Tax DeferredTaxAssetsDeferredStateTax		usd
CY2023Q2	pdex	Deferred Tax Liabilities Deferred State Tax DeferredTaxLiabilitiesDeferredStateTax		usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-14942
CY2023	dei	Entity Registrant Name EntityRegistrantName	PRO-DEX, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1261240
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2361 McGaw Avenue
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92614
CY2023	dei	City Area Code CityAreaCode	949
CY2023	dei	Local Phone Number LocalPhoneNumber	769-3200
CY2023	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2023	dei	Trading Symbol TradingSymbol	PDEX
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	32500000	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3547330	shares
CY2023	dei	Auditor Firm AuditorFirmId	659
CY2023	dei	Auditor Name AuditorName	Moss Adams LLP
CY2023	dei	Auditor Location AuditorLocation	Irvine, California
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2936000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	849000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	1134000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	755000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9952000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15384000	usd
CY2023Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	494000	usd
CY2022Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	710000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	16167000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	12678000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	296000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	790000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	30979000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	31166000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6249000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6343000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5079000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4833000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1872000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2248000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	81000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	118000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	256000	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	7521000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	4083000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42000	usd
CY2023Q2	us-gaap	Assets Assets	51823000	usd
CY2022Q2	us-gaap	Assets Assets	49089000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2261000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3761000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3135000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2751000	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	453000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	544000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1013000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3827000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3285000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9676000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11354000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1638000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2054000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8000	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	8911000	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	10250000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10557000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12304000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	20233000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	23658000	usd
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3545309	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3545309	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3596131	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3596131	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	6767000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	7682000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	24823000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17749000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31590000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	25431000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51823000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49089000	usd
CY2023	us-gaap	Revenues Revenues	46087000	usd
CY2022	us-gaap	Revenues Revenues	42041000	usd
CY2021	us-gaap	Revenues Revenues	38029000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	33338000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	28909000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	24454000	usd
CY2023	us-gaap	Gross Profit GrossProfit	12749000	usd
CY2022	us-gaap	Gross Profit GrossProfit	13132000	usd
CY2021	us-gaap	Gross Profit GrossProfit	13575000	usd
CY2023	us-gaap	Selling Expense SellingExpense	155000	usd
CY2022	us-gaap	Selling Expense SellingExpense	91000	usd
CY2021	us-gaap	Selling Expense SellingExpense	590000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4028000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4903000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4076000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-35000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2804000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2980000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4384000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	6987000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	8009000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9050000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	5762000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	5123000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	4525000	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	294000	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	76000	usd
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	126000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3899000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	931000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1990000	usd
CY2023	pdex	Gain Loss On Investment GainLossOnInvestment	6000	usd
CY2022	pdex	Gain Loss On Investment GainLossOnInvestment	28000	usd
CY2021	pdex	Gain Loss On Investment GainLossOnInvestment	1327000	usd
CY2023	us-gaap	Interest Expense InterestExpense	533000	usd
CY2022	us-gaap	Interest Expense InterestExpense	464000	usd
CY2021	us-gaap	Interest Expense InterestExpense	352000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3666000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	571000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3091000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9428000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5694000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7616000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2354000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1122000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1446000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7074000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4572000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6170000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.98
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.63
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.95
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.21
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.57
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3571044	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3635894	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3796516	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3636944	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3763345	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3936194	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	19062000	usd
CY2021	pdex	Cumulative Effect Of Restatement1 CumulativeEffectOfRestatement1	697000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6170000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	57000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	259000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	901000	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5537000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	21130000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4572000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	60000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1275000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1606000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	25431000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7074000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	77000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	223000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	766000	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1547000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31590000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7074000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4572000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6170000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	857000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	726000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	686000	usd
CY2023	pdex	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment	3899000	usd
CY2022	pdex	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment	931000	usd
CY2021	pdex	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment	1990000	usd
CY2023	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	6000	usd
CY2022	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	28000	usd
CY2021	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	1327000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	84000	usd
CY2023	pdex	Noncash Lease Expense Recovery NoncashLeaseExpenseRecovery	-2000	usd
CY2022	pdex	Noncash Lease Expense Recovery NoncashLeaseExpenseRecovery	13000	usd
CY2021	pdex	Noncash Lease Expense Recovery NoncashLeaseExpenseRecovery	26000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-35000	usd
CY2023	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-12000	usd
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-9000	usd
CY2021	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-49000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	766000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1275000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	901000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	264000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-63000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	89000	usd
CY2022	pdex	Bad Debt Expense Recovery BadDebtExpenseRecovery	2000	usd
CY2021	pdex	Bad Debt Expense Recovery BadDebtExpenseRecovery	-5000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5432000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4449000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5783000	usd
CY2023	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-216000	usd
CY2022	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	517000	usd
CY2021	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	38000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3489000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4241000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	199000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-494000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	331000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	314000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1153000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1991000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	105000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1013000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	863000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-50000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-91000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	147000	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-408000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5462000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-847000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2078000	usd
CY2023	pdex	Payment To Acquire Property Plant And Equipment PaymentToAcquirePropertyPlantAndEquipment	974000	usd
CY2022	pdex	Payment To Acquire Property Plant And Equipment PaymentToAcquirePropertyPlantAndEquipment	1638000	usd
CY2021	pdex	Payment To Acquire Property Plant And Equipment PaymentToAcquirePropertyPlantAndEquipment	1769000	usd
CY2021	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	6499000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	89000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	770000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4596000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	33000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	38000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	334000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-885000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1235000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3710000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6093000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1244000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	351000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5284000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9139000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1547000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1606000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5537000	usd
CY2023	pdex	Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock	-223000	usd
CY2021	pdex	Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock	-259000	usd
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	89000	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	60000	usd
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	96000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2490000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-790000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3088000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2087000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2872000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2700000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	849000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3721000	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6421000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2936000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	849000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3721000	usd
CY2022	pdex	Cashless Stock Option Exercise CashlessStockOptionExercise	45000	usd
CY2021	pdex	Cashless Stock Option Exercise CashlessStockOptionExercise	4000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1655000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1565000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1767000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	521000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	463000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	330000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_zwZyw0x6H5Oi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: left">1.</td><td style="text-align: justify"><span id="xdx_828_zYi7pALoanFl">DESCRIPTION OF BUSINESS</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We specialize in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial markets. We have patented adaptive torque-limiting technology and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, we formed a wholly owned subsidiary, PDEX Franklin, LLC (“PDEX Franklin”), to hold title for an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”) that we acquired on November 6, 2020, in order to allow for the continued growth of our business. The consolidated financial statements include the accounts of the Company and PDEX Franklin and all significant inter-company accounts and transactions have been eliminated. This subsidiary has no separate operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
CY2022Q2	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet	256000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	4083000	usd
CY2022Q2	us-gaap	Assets Assets	49089000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17749000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49089000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	931000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	571000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5694000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1122000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4572000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.21
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1990000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3091000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7616000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1446000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6170000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.63
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.57
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1203000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2752000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1617000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3616000000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3574000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3548000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3695000000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3652000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3623000000	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	1080000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	1082000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	574000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1837000	usd
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3651000000	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3657000000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3626000000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3609000000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3777000000	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3767000000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3749000000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3731000000	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	1115000	usd
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	1787000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2161000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	1107000	usd
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3851000000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3861000000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3817000000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3656000000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3975000000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4012000000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3966000000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3796000000	shares
CY2020Q3	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet	275000	usd
CY2020Q3	us-gaap	Long Term Investments LongTermInvestments	2947000	usd
CY2020Q3	us-gaap	Assets Assets	31451000	usd
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8122000	usd
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31451000	usd
CY2020Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-166000	usd
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-167000	usd
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1382000	usd
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	267000	usd
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	1115000	usd
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2020Q4	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet	261000	usd
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	3927000	usd
CY2020Q4	us-gaap	Assets Assets	39063000	usd
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9909000	usd
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39063000	usd
CY2020Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1464000	usd
CY2020Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1409000	usd
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1930000	usd
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	usd
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	1787000	usd
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
CY2021Q1	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet	250000	usd
CY2021Q1	us-gaap	Long Term Investments LongTermInvestments	3757000	usd
CY2021Q1	us-gaap	Assets Assets	43037000	usd
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12071000	usd
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43037000	usd
CY2021Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	178000	usd
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	900000	usd
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2765000	usd
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	604000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2161000	usd
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2021Q3	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet	187000	usd
CY2021Q3	us-gaap	Long Term Investments LongTermInvestments	2994000	usd
CY2021Q3	us-gaap	Assets Assets	42927000	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14257000	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42927000	usd
CY2021Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	171000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	75000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1393000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	313000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	1080000	usd
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2021Q4	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet	128000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	3494000	usd
CY2021Q4	us-gaap	Assets Assets	43333000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15338000	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	7014000	usd
CY2023Q1	us-gaap	Assets Assets	51691000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	649000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43333000	usd
CY2021Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-84000	usd
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-176000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1426000	usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	344000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	1082000	usd
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2022Q1	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet	85000	usd
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	3487000	usd
CY2022Q1	us-gaap	Assets Assets	45215000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15912000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45215000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-120000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-232000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	789000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	215000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	574000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2022Q3	pdex	Deferred Income Tax Asset Net DeferredIncomeTaxAssetNet	175000	usd
CY2022Q3	us-gaap	Long Term Investments LongTermInvestments	4368000	usd
CY2022Q3	us-gaap	Assets Assets	49855000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	18952000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49855000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	425000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	519000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1469000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	266000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1203000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	6787000	usd
CY2022Q4	us-gaap	Assets Assets	51876000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	534000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	23639000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	21704000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51876000	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2740000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2619000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3756000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1004000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2752000	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
CY2023Q1	us-gaap	Liabilities Liabilities	21785000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	23321000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51691000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	242000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	122000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2187000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	570000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1617000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
CY2023	pdex	Revenue Recognition Sale Of Services RevenueRecognitionSaleOfServices	<p id="xdx_849_ecustom--RevenueRecognitionSaleOfServices_zSVepBPFBji2" style="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0"><b><span id="xdx_869_zVgbrhk8nUx7">Net Sales</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 0.5in">Net sales consists of the sale of products and services, as well as shipping and handling costs billed to our customers and is net of volume rebates and discounts and excludes sales tax.</p>
CY2023	us-gaap	Profit Loss ProfitLoss	108000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	0	usd
CY2023	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p id="xdx_849_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zAhnwJtrNBIk" style="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0"><b><span id="xdx_86E_zRNjEE2891ij">Warranties</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 0.5in">Certain of our products are sold with a warranty that provides for repairs or replacement of any defective parts for a period, generally one to two years, after the sale. At the time of the sale, we accrue an estimate of the cost of providing the warranty based on prior experience with such factors as return rates and repair costs, which factors are reviewed quarterly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 0.5in">The warranty accrual is based on historical costs of warranty repairs and expected future identifiable warranty expenses and is included in accrued expenses in the accompanying balance sheets. Warranty expenses are included in cost of sales in the accompanying statements of operations. Changes in estimates to previously established warranty accruals result from current period updates to assumptions regarding repair costs and warranty return rates and are included in current period warranty expense.</p>
CY2023Q2	us-gaap	Other Inventory In Transit OtherInventoryInTransit	637000	usd
CY2022Q2	us-gaap	Other Inventory In Transit OtherInventoryInTransit	177000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zNyn1M5OKHhe" style="font: 10pt Times New Roman, Times, Serif; margin: 7pt 0 0"><b><span id="xdx_86C_zyNRDR3Ihxyb">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 7pt 0 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject us to credit risk consist principally of cash, cash equivalents, and trade receivables. We place our cash and cash equivalents with major financial institutions. At June 30, 2023 and 2022, and throughout the fiscal years then ended, we had deposits in excess of federally insured limits. Credit sales are made to medical device distributors, original equipment manufacturers, and resellers throughout the world, and sales to such customers account for a substantial portion of our trade receivables. While such receivables are not collateralized, we evaluate their collectability based on several factors including customers’ payment histories.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zNj6C3uIUL2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0in"><b><span id="xdx_86D_zBJeBfIx58c4">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 7pt 0 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 7pt 0 0; text-align: justify; text-indent: 0.5in">Our operations are affected by numerous factors including market acceptance of our products, supply chain disruptions, changes in technologies, and new laws, effects from the COVID-19 pandemic, government regulations, and policies. We cannot predict what impact, if any, the occurrence of these or other events might have on our operations. Significant estimates and assumptions made by management include, but are not limited to, revenue recognition, share-based compensation, the allowance for doubtful accounts, accrued warranty expense, investments, inventory valuation, the carrying value of long-lived assets, and the recoverability/extinguishment of deferred income tax assets and liabilities.</p>
CY2023	us-gaap	Advertising Expense AdvertisingExpense	4000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	1000	usd
CY2023	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	2695000	usd
CY2022	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	1014000	usd
CY2023	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	43392000	usd
CY2022	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	41027000	usd
CY2023	us-gaap	Revenues Revenues	46087000	usd
CY2022	us-gaap	Revenues Revenues	42041000	usd
CY2023Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1000000	usd
CY2022Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	98000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	710000	usd
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	193000	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	1545000	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	1319000	usd
CY2023	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-1710000	usd
CY2022	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-774000	usd
CY2023	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-51000	usd
CY2022	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-28000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	494000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	710000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1013000	usd
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	150000	usd
CY2023	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	781000	usd
CY2022	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	1482000	usd
CY2023	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-1794000	usd
CY2022	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-619000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1013000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5079000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1134000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	755000	usd
CY2023Q2	pdex	Marketable Securities Warrant Non Current MarketableSecuritiesWarrantNonCurrent	6160000	usd
CY2022Q2	pdex	Marketable Securities Warrant Non Current MarketableSecuritiesWarrantNonCurrent	2304000	usd
CY2023Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1361000	usd
CY2022Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1779000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	8655000	usd
CY2022Q2	us-gaap	Marketable Securities MarketableSecurities	4838000	usd
CY2023Q2	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	2714000	usd
CY2022Q2	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	2796000	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	219000	usd
CY2023	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	286000	usd
CY2023	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	67000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	262000	usd
CY2022	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	369000	usd
CY2022	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	107000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1134000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	755000	usd
CY2023Q2	us-gaap	Share Price SharePrice	3.98
CY2022Q2	us-gaap	Share Price SharePrice	3.02
CY2023	us-gaap	Option Indexed To Issuers Equity Strike Price1 OptionIndexedToIssuersEquityStrikePrice1	0.69
CY2022	us-gaap	Option Indexed To Issuers Equity Strike Price1 OptionIndexedToIssuersEquityStrikePrice1	1.60
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P2Y5M23D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P3Y5M23D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.600	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.600	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0468	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0300	pure
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4833000	usd
CY2023	us-gaap	Depreciation Depreciation	727000	usd
CY2022	us-gaap	Depreciation Depreciation	616000	usd
CY2023Q2	pdex	Retired Assets RetiredAssets	760000	usd
CY2022Q2	pdex	Retired Assets RetiredAssets	87000	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	8824000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	6323000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3686000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3463000	usd
CY2023Q2	pdex	Inventory Sub Assemblies InventorySubAssemblies	2387000	usd
CY2022Q2	pdex	Inventory Sub Assemblies InventorySubAssemblies	2118000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1270000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	774000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	16167000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	12678000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	6499000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	6499000	usd
CY2023Q2	pdex	Accumulated Depreciation AccumulatedDepreciation	250000	usd
CY2022Q2	pdex	Accumulated Depreciation AccumulatedDepreciation	156000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6249000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6343000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13390000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13177000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8311000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8344000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	35000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	127000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	90000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	81000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	118000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16000	usd
CY2022	us-gaap	Legal Fees LegalFees	84000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	30000	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	650000	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	509000	usd
CY2023Q2	pdex	Unvouchered Inventory In Transit Current UnvoucheredInventoryInTransitCurrent	637000	usd
CY2022Q2	pdex	Unvouchered Inventory In Transit Current UnvoucheredInventoryInTransitCurrent	177000	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	216000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	275000	usd
CY2023Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	400000	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	430000	usd
CY2023Q2	pdex	Operating Lease Liability Currents OperatingLeaseLiabilityCurrents	416000	usd
CY2022Q2	pdex	Operating Lease Liability Currents OperatingLeaseLiabilityCurrents	379000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	200000	usd
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	340000	usd
CY2023Q2	pdex	Accrued Losses On Development Contracts Current AccruedLossesOnDevelopmentContractsCurrent	480000	usd
CY2022Q2	pdex	Accrued Losses On Development Contracts Current AccruedLossesOnDevelopmentContractsCurrent	517000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	136000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	124000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3135000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2751000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	340000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	221000	usd
CY2023	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	161000	usd
CY2022	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	177000	usd
CY2023	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-109000	usd
CY2022	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	54000	usd
CY2023	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	192000	usd
CY2022	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	112000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	200000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	340000	usd
CY2023	us-gaap	Product Warranty Expense ProductWarrantyExpense	52000	usd
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	231000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1745000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	733000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	345000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	451000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	6000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	23000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	258000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-85000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2354000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1122000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9428000	usd
CY2023	pdex	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Tax Rate IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestTaxRate	1	pure
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5694000	usd
CY2022	pdex	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Tax Rate IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestTaxRate	1	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1979000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1183000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	672000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07	pure
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	266000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.05	pure
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	229000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.02	pure
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	205000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.04	pure
CY2023	pdex	Uncertain Tax Positions UncertainTaxPositions	119000	usd
CY2023	pdex	Uncertain Tax Position UncertainTaxPosition	-0.01	pure
CY2022	pdex	Uncertain Tax Positions UncertainTaxPositions	76000	usd
CY2022	pdex	Uncertain Tax Position UncertainTaxPosition	-0.01	pure
CY2023	pdex	Income Tax Reconciliation Share Based Compensation IncomeTaxReconciliationShareBasedCompensation	114000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.01	pure
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	165000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.01	pure
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-46000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.01	pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2354000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1122000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.20	pure
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	22000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	22000	usd
CY2023Q2	pdex	Deferred Tax Assets Research And Other Credits DeferredTaxAssetsResearchAndOtherCredits	65000	usd
CY2022Q2	pdex	Deferred Tax Assets Research And Other Credits DeferredTaxAssetsResearchAndOtherCredits	65000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	122000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	163000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	267000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	322000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	814000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	651000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	35000	usd
CY2023Q2	pdex	Section174 Capitalization Section174Capitalization	830000	usd
CY2023Q2	pdex	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	599000	usd
CY2022Q2	pdex	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	713000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	351000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	514000	usd
CY2023Q2	pdex	Deferred Tax Assets Deferred State Tax DeferredTaxAssetsDeferredStateTax	31000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3101000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2485000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	91000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	98000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3010000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2387000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	767000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	820000	usd
CY2023Q2	pdex	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	546000	usd
CY2022Q2	pdex	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	658000	usd
CY2022Q2	pdex	Deferred Tax Liabilities Deferred State Tax DeferredTaxLiabilitiesDeferredStateTax	77000	usd
CY2023Q2	pdex	Deferred Tax Assets Unrealized Gain On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedGainOnAvailableforSaleSecuritiesGross	1705000	usd
CY2022Q2	pdex	Deferred Tax Assets Unrealized Gain On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedGainOnAvailableforSaleSecuritiesGross	541000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	35000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3018000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2131000	usd
CY2023Q2	pdex	Deferred Tax Asset Liabilities Net DeferredTaxAssetLiabilitiesNet	-8000	usd
CY2022Q2	pdex	Deferred Tax Asset Liabilities Net DeferredTaxAssetLiabilitiesNet	256000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7000	usd
CY2023Q2	pdex	Unrecognized Tax Benefit UnrecognizedTaxBenefit	345000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	509000	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	550000	usd
CY2023	pdex	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions On Federal Tax UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsOnFederalTax	16000	usd
CY2022	pdex	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions On Federal Tax UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsOnFederalTax	33000	usd
CY2023	pdex	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions Upon State Tax UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsUponStateTax	19000	usd
CY2022	pdex	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions Upon State Tax UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsUponStateTax	26000	usd
CY2023	pdex	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Position UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPosition	-95000	usd
CY2022	pdex	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Position UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPosition	9000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	104000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	109000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	345000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	509000	usd
CY2023	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	45000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3844000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1397000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1451000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1508000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	908000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3689000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	12797000	usd
CY2023Q2	pdex	Operating Lease Liability Currents OperatingLeaseLiabilityCurrents	416000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	519000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	535000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	551000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	567000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	143000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2315000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	261000	usd
CY2023Q2	pdex	Operating Lease Liabilities OperatingLeaseLiabilities	2054000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053	pure
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	504000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	489000	usd
CY2023	pdex	Lease And Rental Expenses LeaseAndRentalExpenses	563000000	usd
CY2022	pdex	Lease And Rental Expenses LeaseAndRentalExpenses	559000000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7074000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4572000	usd
CY2023	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3571000	shares
CY2022	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3636000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.98
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7074000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4572000	usd
CY2023	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3571000	shares
CY2022	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3636000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	66000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	127000	shares
CY2023	pdex	Weightedaverage Shares Used In Calculation Of Diluted Earnings Per Share WeightedaverageSharesUsedInCalculationOfDilutedEarningsPerShare	3637000	shares
CY2022	pdex	Weightedaverage Shares Used In Calculation Of Diluted Earnings Per Share WeightedaverageSharesUsedInCalculationOfDilutedEarningsPerShare	3763000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.95
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.21

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001079973-23-001429-index-headers.html	Edgar Link	pending
0001079973-23-001429-index.html	Edgar Link	pending
0001079973-23-001429.txt	Edgar Link	pending
0001079973-23-001429-xbrl.zip	Edgar Link	pending
ex10x31.htm	Edgar Link	pending
ex10x32.htm	Edgar Link	pending
ex21.htm	Edgar Link	pending
ex23.htm	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
ex4x1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pdex-20230630.xsd	Edgar Link	pending
pdex_10k-063023.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
pdex-20230630_cal.xml	Edgar Link	unprocessable
pdex-20230630_def.xml	Edgar Link	unprocessable
pdex-20230630_lab.xml	Edgar Link	unprocessable
pdex-20230630_pre.xml	Edgar Link	unprocessable
pdex_10k-063023_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PDEX
PRO DEX INC Stock $pdex

2023 Q3 Form 10-K Financial Statement

#000107997323001429 Filed on October 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX PRO DEX INC Stock $pdex

2023 Q3 Form 10-K Financial Statement

#000107997323001429 Filed on October 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX
PRO DEX INC Stock $pdex